Exclusive: Third death revealed in China's popular but opaque trials
A patient with an autoimmune disease has died after receiving an experimental genetic medicine from a biotech startup in China, Endpoints News has learned. The Shanghai-based company, RiboX Therapeutics, recently received a green light from ...
August 18, 2026 10:25 AM EDT R&DChina Exclusive: Third death in China's popular but opaque trials revealed, this time in CAR-T Ryan Cross Senior Science Correspondent A patient with an autoimmune disease has died after receiving an experimental genetic medicine from a biotech startup in China, Endpoints News has learned. The … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that